Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arnold, Michelle
TIGeR-PaC, NCT03257033 / 2019-002288-84: Intra-arterial Gemcitabine Vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC	Recruiting	3	190	Europe, US	Gemcitabine, Gemzar, nab-paclitaxel, Abraxane, RenovoCath	RenovoRx, RenovoRx	Locally Advanced Pancreatic Cancer	06/26	09/26
NCT04534387: Development and Assessment of a Spanish-Language Hearing Loss Toolkit for Self-Management	Recruiting	N/A	110	US	Spanish-Language Hearing Loss Toolkit for Self-Management, American Speech-Language-Hearing Association (ASHA) Audiology Series Spanish Language Handouts	University of South Florida, National Institute on Deafness and Other Communication Disorders (NIDCD)	Hearing Loss	03/24	03/24
P-EARLHI, NCT05970211: Early Age-Related Hearing Loss Investigation Pilot Study	Recruiting	N/A	40	US	Phonak Audeo Lumity Receiver in Canal Hearing Aid	University of South Florida	Hearing Loss	04/24	08/24